PKM and neoplasm: Subsequently, this interaction diminishes glycolytic metabolism and heightens nuclear translocation of PKM2, thereby mitigating apoptotic pathways in tumor cells through the modulation of the MEK/ERK/PIN1 signaling axis187 (Table 2).